Prediction of Postpartum Depression: Take a Closer Look at Question 3 on the PHQ-9
A routinely administered single-item measure of sleep disturbance could identify pregnant individuals who are at risk for PPD and may benefit from depression prevention efforts.
Using Metabolic Biomarkers to Predict Risk for Postpartum Depression
Metabolic biomarkers in the cerebrospinal fluid may be used to identify women at high risk for postpartum depression.
New Oral PPD Treatment Zuranolone Will Soon Hit the Market as Zurzuvae
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
Treating Insomnia During Pregnancy: Is Trazodone Safe?
More study is needed regarding the safety of trazodone for the treatment of insomnia during pregnancy.
Weekly Roundup for October 27, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Update on Postpartum Depression Documentary: More Than Blue
We are looking to include two additional women who are early on in the postpartum period (under one year) and recovering from postpartum depression.